Endurant Capital Management’s Arcus Biosciences RCUS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-97,327	Closed	-$2.55M	–	69
2022 Q3	$2.55M	Buy	97,327 +32,571	+50%	+$852K	0.83%	29
2022 Q2	$1.64M	Buy	64,756 +26,106	+68%	+$662K	0.58%	34
2022 Q1	$1.22M	Buy	+38,650	New	+$1.22M	0.32%	48